|
Quote |
Price | |
$19.02 |
|
Price change for today in $ | |
0.09 |
|
Price change for today in % | |
0.48 |
|
Open Price | |
$19.01 |
|
Previous Close | |
$18.93 |
|
Daily Range | |
$18.64 - $19.31 |
|
52-Week Range | |
$11.02 - $34.91 |
|
Volume | |
474,349 |
|
| |
 |
| |
Brokerage Analyst Recommendations
|
| 21 Brokerage Firms Covering NUVA |
| |
|
Strong Buy
12 |
Buy
1 |
Hold
8 |
Sell
0 |
Strong Sell
0 |
|
| Average Broker Recommendation (ABR):1.81 |
| |
|
| Description |
| NUVASIVE is a medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders. The Company's product portfolio is focused on applications in the over $4.2 billion U.S. spine fusion market. The Company's current principal product offering includes a minimally disruptive surgical platform called Maximum Access Surgery, or MAS, as well as a growing offering of cervical and motion preservation products. |
| |
|
|
